Wave to price its IPO of 5 million shares between $15.00 and $17.00

Financing to be conducted by bookrunners Jefferies, Leerink Partners

By Devika Patel

Knoxville, Tenn., Nov. 9 – Wave Life Sciences Pte. Ltd. will sell 5 million ordinary shares in its initial public offering with a 30-day greenshoe option of 750,000 additional shares, according to a Form S-1/A filed Monday with the Securities and Exchange Commission. The company had previously registered up to $80 million of stock for the deal, which was announced on Oct. 9.

The shares will be sold at a price expected to fall between $15.00 and $17.00 per share.

Jefferies LLC and Leerink Partners LLC are the bookrunners and JMP Securities and SunTrust Robinson Humphrey are co-managers.

Proceeds will be used for preclinical studies, for clinical trials, to advance discovery programs, to expand the company’s pipeline, for working capital and for other general corporate purposes.

The biopharmaceutical company is based in Singapore. The company intends to list its common stock on the Nasdaq under the symbol “WVE.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.